Article Boron Compounds In-vitro Studies Year 2007

Synthesis, liposomal preparation, and in vitro toxicity of two novel dodecaborate cluster lipids for boron neutron capture therapy

Bioconjugate Chemistry, 2007

Authors:   Eugen Justus, Doaa Awad, Michaela Hohnholt, Tanja Schaffran, Katarina Edwards, Göran Karlsson, Luminita Damian, Detlef Gabel
Journal: Bioconjugate Chemistry
Abstract: A new class of lipids, containing the closo-dodecaborate cluster, has been synthesized. Two lipids, S-(N, N-(2-dimyristoyloxyethyl)acetamido)thioundecahydro-closo-dodecaborate (2-) (B-6−14) and S-(N, N-(2-dipalmitoyloxyethyl)acetamido)thioundecahydro-closo-dodecaborate (2-) (B-6−16) are described. Both of them have a double-tailed lipophilic part and a headgroup carrying two negative charges. Differential scanning calorimetry shows that B-6−14 and B-6−16 bilayers have main phase transition temperatures of 18.8 and 37.9 °C, respectively. Above the transition temperature of 18.8 °C, B-6−14 can form liposomal vesicles, representing the first boron-containing lipid with this capability. Upon cooling below the transition temperature, stiff bilayers are formed. When incorporated into liposomal formulations with equimolar amounts of distearoyl phosphatidylcholine (DSPC) and cholesterol, stable liposomes are obtained. The ζ-potential measurements indicate that both B-6−14- and B-6−16-containing vesicles are negatively charged, with the most negative potential described of any liposome so far. The liposomes are of high potential value as transporters of boron to tumor cells in treatments based on boron neutron capture therapy (BNCT). Liposomes prepared from B-6−14 were slightly less toxic in V79 Chinese hamster cells (IC50 5.6 mM) than unformulated Na2B12H11SH (IC50 3.9 mM), while liposomes prepared from B-6−16 were not toxic even at 30 mM.